ArticleSkin health and disease2024

Re-engagement, quality of life, and burden of treatment in adults on dupilumab for severe atopic dermatitis-A mixed methods study.

Emma Porter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.